Simpler Grants.gov #FOR-HL-25-020

NHLBI Forecast: Expansion of CTSN Cardiac Surgery Research Platform

The National Heart, Lung, and Blood Institute (NHLBI) is planning a funding opportunity to expand the Cardiothoracic Surgical Trials Network (CTSN) research platform. - Government Buyer: - National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) - Scope of Opportunity: - Expansion of the CTSN international cardiac surgery research platform - New research areas: dissemination and implementation science, circadian medicine, mechanistic science - Focus on interventional cardiology and peri-operative care of cardiac patients - Collaboration Sought: - Academia, small businesses, professional societies, foundations, and international research entities - Products/Services Requested: - Research projects, development of new techniques, technologies, devices, and innovative pharmaceutical and bioengineered products - Training for clinical trialists and implementation researchers - Notable Requirements: - No specific OEMs, vendors, products, or purchase quantities identified - Emphasis on collaborative, innovative research and training - OEMs: - No OEMs or specific manufacturers are named, as this is a research grant forecast - Place of Performance: - National Institutes of Health (NIH)

Description

The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on expanding an international cardiac surgery research platform. This platform currently includes interventional cardiology and peri-operative care of cardiac patients and will be expanded to incorporate other areas such as dissemination and implementation science, circadian medicine, and mechanistic science. The platform aims to facilitate collaboration among academia, small businesses, professional societies, foundations, and international research entities to advance new techniques, technologies, devices, and innovative pharmaceutical and bioengineered products. It also aims to train the next generation of clinical trialists and implementation researchers. Applications are not being solicited at this time; this notice is to allow potential applicants time to develop collaborations and projects.

View original listing